Delphine Mariotte

Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis

Delphine Mariotte, Benoît Dupont, Radj Gervais et al. · mAbs · 2011 · 59 citations · Full text

Hsr Events, Allergy Medicine, Immunodeficiencies +20

Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis

Samuel Deshayes, Achille Aouba, Kathy Khoy et al. · PLoS ONE · 2018 · 42 citations · Full text

Immunohematology, Vasculitis, Immunodeficiencies +29

Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.

E. Comby, Pascale Tanaff, Delphine Mariotte et al. · PubMed · 2006 · 40 citations

CD49d expression as a promising biomarker to monitor natalizumab efficacy

Gilles Defer, Delphine Mariotte, Nathalie Derache et al. · Journal of the Neurological Sciences · 2011 · 39 citations

Autoimmune Disease, Novel Therapy, Cd49d Expression +10

The importance of EN ISO 15189 accreditation of allergen-specific IgE determination for reliable<i>in vitro</i>allergy diagnosis

Claude Lambert, A. Sarrat, F. Bienvenu et al. · Allergy · 2014 · 32 citations